✦ LIBER ✦

Assessment of molecular remission rate after bortezomib plus dexamethasone induction treatment and autologous stem cell transplantation in newly diagnosed multiple myeloma patients

✍ Scribed by Silvennoinen, Raija; Kairisto, Veli; Pelliniemi, Tarja-Terttu; Putkonen, Mervi; Anttila, Pekka; Säily, Marjaana; Sikiö, Anu; Opas, Jorma; Penttilä, Karri; Kuittinen, Taru; Honkanen, Tuomo; Lundán, Tuija; Juvonen, Vesa; Luukkaala, Tiina; Remes, Kari

Book ID: 119827046
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 123 KB
Volume: 160
Category: Article
ISSN: 0007-1048
DOI: 10.1111/bjh.12139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-Effectiveness of Induction Treatmen

Cost-Effectiveness of Induction Treatment with Bortezomib Added to Thalidomide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplantation in Germany

✍ van Beurden-Tan, C.; Rosiñol, L.; Diels, J.; Wirth, D.; Chirita, O.; Lahuerta, J 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Bortezomib Plus Dexamethasone Is Superio

Bortezomib Plus Dexamethasone Is Superior to Vincristine Plus Doxorubicin Plus Dexamethasone As Induction Treatment Prior to Autologous Stem-Cell Transplantation in Newly Diagnosed Multiple Myeloma: Results of the IFM 2005-01 Phase III Trial

✍ Harousseau, J.-L.; Attal, M.; Avet-Loiseau, H.; Marit, G.; Caillot, D.; Mohty, M 📂 Article 📅 2010 🏛 American Society of Clinical Oncology 🌐 English ⚖ 165 KB

Bortezomib with thalidomide plus dexamet

Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

✍ Michele Cavo; Paola Tacchetti; Francesca Patriarca; Maria Teresa Petrucci; Lucia 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 276 KB

Thalidomide-Dexamethasone as Induction T

Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency

✍ Patrizia Tosi; Elena Zamagni; Paola Tacchetti; Michela Ceccolini; Giulia Perrone 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 345 KB

A staged approach with vincristine, adri

A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

✍ C. S. Chim; A. K. W. Lie; E. Y. T. Chan; Y. Y. Leung; S. C. W. Cheung; S. Y. T. 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 319 KB

Two cycles of the PS-341/bortezomib, adr

Two cycles of the PS-341/bortezomib, adriamycin, and dexamethasone combination followed by autologous hematopoietic cell transplantation in newly diagnosed multiple myeloma patients

✍ Jung-Hee Lee; Je-Hwan Lee; Dae-Young Kim; Sung-Doo Kim; Yunsuk Choi; Young-Ah Ka 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB